Biotech Stock Review, Dyve Pharma

Dyve Biosciences (Private) Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for...

THOUSAND OAKS, Ca.--(BUSINESS WIRE)--Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed with a...
Mitesco, Biotech Stock Review

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.

This is a Welcome Step in the Right Direction. ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB:...
True Nature, Mitesco, Biotech Stock Review

Is True Nature (TNTY) $0.04, Nearing a Breakout?

After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible Breakout. Only time...
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders. "Been there, done that -...
AR THreats Report, Biotech Stock Reciew

AR Threats Report (CDC)

This report is dedicated to the 48,700 familieswho lose a loved one each year to antibiotic resistanceor Clostridioides difficile, and the countless healthcareproviders, public...
biogen, biotech stock review

Biotech’s Turning Up…

Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News. We keep telling investors (for 40+ years) it's not stock picking...
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it appears that...
Dyadic, Biotech Stock Review

Dyadic (DYAI) Highlights.

"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and animal health...
Mustang Bio, Biotech Stock Review

Mustang Bio (MBIO) Highlights.

"With a strong balance sheet and the continued advancement of our gene therapy and CAR T programs, we are well-positioned to execute on our...

Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...

We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff from the...

Latest article

Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Adding to Watch List....

In 2020, we Released the "Biotech 5 Pack" Which Later Grew to a 6 Pack, with a Byline "6 Stocks We Expect to Double"...

REPORT OpenWorld: The Contrarian’sCase for OPNW

Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some. LIVE QUOTE RECENT NEWS VerifyMe Reports Fourth Quarter...

$269 Million in Cash and a $178 Million Market Cap. What are the Odds?...

Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but don't go crazy, we're down to $269...